Ultromics
Latest round
- Series C
Last raised
- Jun 2025
Total raised
- $127M
Investors
- 15
About Ultromics
Founded in 2017 in Oxford, UK, Ultromics Limited focuses on improving cardiac diagnostics through its AI-enhanced echocardiography technologies. The CEO is Ross Upton, and the firm has executed 5 deals, with the most recent occurring in July 2025. Ultromics specializes in advanced echocardiography solutions, leveraging clinically validated artificial intelligence to enhance the diagnosis of complex cardiac diseases. Their flagship product, the EchoGo® platform, operates in the background of existing workflows, seamlessly integrating with medical infrastructure to provide detailed analysis of routine echocardiograms. This innovative technology primarily addresses the diagnosis of heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis, conditions that often go unrecognized due to diagnostic challenges.5% sensitivity for cardiac amyloidosis. Ultromics serves a diverse client base, including healthcare providers, hospitals, and cardiology clinics across various geographical markets, focusing on North America and Europe.50.
Who invested in Ultromics
15 investors across 4 rounds
See all investors in Ultromics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ultromics
Who invested in Ultromics?
Ultromics has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ultromics raised?
Ultromics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Ultromics last raise money?
Ultromics's most recent round on record is a Series C, in Jun 2025.
What does Ultromics do?
Founded in 2017 in Oxford, UK, Ultromics Limited focuses on improving cardiac diagnostics through its AI-enhanced echocardiography technologies.
Where is Ultromics headquartered?
Ultromics is headquartered in Oxford, UK.
Which VCs invest in companies like Ultromics?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Marktlink Capital back software companies at Ultromics's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Ultromics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.